On March 22, 2025, the 22nd CACLP kicked off at the Hangzhou International Expo Center, gathering over 1,000 exhibitors from 50+ countries and regions as a top-tier IVD industry event. Beadstar Bio made a standout debut with its independently developed low-adsorption magnetic fluorescent encoded microspheres and multiplex cytokine detection kits, capturing wide attention from research institutions, medical facilities, and industry partners.

Founded by an interdisciplinary PhD team, Beadstar Bio has conquered key technical barriers in flow cytometry. Its 300+ high-performance microsphere products feature a unique surface modification process that minimizes non-specific protein adsorption, boosting detection sensitivity by over 30% versus traditional microspheres. Complemented by mouse and human multiplex cytokine kits—covering 20+ core factors like IL-2, IL-6, and TNF-α—the products enable simultaneous analysis of up to 20 cytokines in one experiment, supporting tumor research, autoimmune disease monitoring, and drug efficacy evaluation.

During the expo, Beadstar Bio showcased microsphere advantages via dynamic demos and hosted a roadshow titled "The Evolution Path of Magnetic Fluorescent Encoded Microspheres." It also forged in-depth collaborations with global IVD enterprises, universities, and investors, focusing on technology standardization and automated application expansion. With a vision to lead the industry in solutions and applications, Beadstar Bio’s CACLP appearance highlighted its technical strength in multiplex detection, paving the way for deeper cooperation and advancing global IVD innovation.